Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Wohlfarth, Philipp  [Clear All Filters]
2023
Cserna J, Baumann CK, Lobmeyr E, Grafeneder J, Ettl F, Eibensteiner F, Rabitsch W, Mitterbauer M, Knaus HA, Wohlfarth P. Emergency department utilization following allogeneic hematopoietic stem cell transplantation: a single-center retrospective longitudinal analysis of 557 patients. Transplant Cell Ther. 2023.
Di Nardo M, MacLaren G, Schellongowski P, Azoulay E, DeZern AE, Gutierrez C, Antonelli M, Antonini MV, Beutel G, Combes A, et al. Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement. Lancet Respir Med. 2023.
2022
Lueck C, Tzalavras A, Wohlfarth P, Meedt E, Kiehl M, Turki AT, Hoeper MM, Eder M, Cserna J, Buchtele N, et al. Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplant. 2022.
2020
Strobl J, Pandey RVinay, Kausgruber T, Kleißl L, Reininger B, Herac M, Bayer N, Krall C, Wohlfarth P, Mitterbauer M, et al. Anti-apoptotic molecule BCL2 is a therapeutic target in steroid-refractory graft-versus-host disease. J Invest Dermatol. 2020.
Handisurya A, Worel N, Rabitsch W, Bojic M, Pajenda S, Reindl-Schwaighofer R, Winnicki W, Vychytil A, Knaus HA, Oberbauer R, et al. Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation. Front Med (Lausanne). 2020;7:585628.
2018
Turki AT, Lamm W, Schmitt C, Bayraktar E, Alashkar F, Metzenmacher M, Wohlfarth P, Beelen DW, Liebregts T. Correction to: Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients. Ann Hematol. 2018.